S. Korea begins reviewing 1st blood plasma therapy for COVID-19

SEOUL, April 30 (Yonhap) -- South Korea's drug safety agency said Friday that it has begun reviewing a plasma therapy treatment against the novel coronavirus by local biotech company GC Pharma for